MMM
3M CO
Healthcare • NYSE • CIK 0000066740
Loading...
Market Cap
$84.66B
P/E (TTM)
29.0x
Rev Growth (TTM)
+2.3%
Net Margin (TTM)
11.9%
FCF Yield (TTM)
4.7%
FCF Margin (TTM)
15.8%
Figures as of June 30, 2026
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
8-KSep 20262026-09-10source
8-KAug 20262026-08-19source
10-Q2026 Q22026-07-21source
8-KEarnings2026-07-21source
8-KJun 20262026-06-08source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q2
2 months ago
8-K releaseRevenue
$6.50B
+2.5%
Net Income
$938.00M
—
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow5/8 positive
TTM$4.0B
Q2 '26
$763.0M+119%
Q1 '26
$349.0M-74%
FCF Margin
TTM15.8%
Q2 '2611.7%+103%
Sector: 0.7%Top 25%
OCF Margin
19.5%
OCF/NI1.63x
CapEx Coverage
5.4x
FCF Yield4.7%
FCF Growth (3Y)-4%
Cash Conversion Cycle
78 days
DSO: 54+DIO: 91−DPO: 67
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM6.6%
Div Yield1.8%
+Buyback (TTM)4.7%
Dividend & Payout Metrics
Dividend Yield (TTM)1.8%
FCF Payout Ratio38.8%
Free Cash Flow (TTM)$4.0B
Stock Repurchases (TTM)$4.0B
Capital Return / FCF140.7%
Shares Outstanding (YoY)-3.2%↓ Buyback
Est. Dividends Paid (TTM)$1.5B
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
29.0x
Volatile
8Q: 24.3x+1175%
Multiple expansion without fundamental improvement
Valuation Lenses
Earnings
29.0x
vs – sector
Cash Flow
23.7x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
1.7P/E per %ROIC
ROIC: 16.9%
Shareholder Returns
Dividend
1.8%
Buyback
4.7%
Total Yield
6.6%
Market Cap$84.66B
EV$94.25B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
39.4%
Operating
18.4%
Top 25% in sector
Net
11.9%
Margins Unknown
Return on Invested CapitalTTM
16.9%
Stable
-0.0% YoY8Q: 19.3%-3.8%
P25MedianP75
75th pctl (med: -7.4%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.1%
8Q: 16.5%
Asset Turnover
0.68x
8Q: 0.65x
Leverage (1+D/E)
5.25x
D/E: 4.25x
DuPont: 50.8% ≈ 16.9% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
3.54x
8Q:3.43x
+37.8%
Invested Cap Turn
1.19x
8Q:1.18x
+6.5%
CapEx Intensity
4.3%
8Q:4.5%
CapEx/Depreciation
0.66x
FCF vs Net Margin Gap+3.9 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
ND/EBITDA 1.4x
Net Debt / EBITDA
1.4xNet Debt: $9.60B
Interest Coverage
5.3x
+Strong interest coverage: 5.3x
Leverage Metrics
Debt-to-Equity
4.25x
Balance sheet risk & solvency analysis
Related Research
2 related posts